Bruker Corp Files Q3 2024 10-Q

Ticker: BRKRP · Form: 10-Q · Filed: Nov 7, 2024 · CIK: 1109354

Bruker Corp 10-Q Filing Summary
FieldDetail
CompanyBruker Corp (BRKRP)
Form Type10-Q
Filed DateNov 7, 2024
Risk Levellow
Pages15
Reading Time18 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, quarterly-report

TL;DR

Bruker Corp's Q3 2024 10-Q is in. Check financials.

AI Summary

Bruker Corp filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial performance and position. Key financial data points and disclosures are provided within this report.

Why It Matters

This filing provides investors and analysts with the latest financial details for Bruker Corp, crucial for understanding the company's performance and making informed investment decisions.

Risk Assessment

Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks highlighted.

Key Players & Entities

  • BRUKER CORP (company) — Filer
  • 20240930 (date) — Period of Report
  • 20241107 (date) — Filing Date
  • 0001109354 (company) — Central Index Key

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240930, indicating the filing covers the period ending September 30, 2024.

When was this 10-Q filing submitted to the SEC?

The filing was submitted on 20241107.

What is Bruker Corp's Central Index Key (CIK)?

Bruker Corp's Central Index Key is 0001109354.

What is the Standard Industrial Classification (SIC) code for Bruker Corp?

Bruker Corp's SIC code is 3826, which corresponds to Laboratory Analytical Instruments.

What is the company's state of incorporation?

Bruker Corp is incorporated in Delaware (DE).

Filing Stats: 4,443 words · 18 min read · ~15 pages · Grade level 7.1 · Accepted 2024-11-07 16:06:59

Key Financial Figures

  • $0.01 — ing at November 4, 2024 Common Stock, $0.01 par value per share 151,598,240 share

Filing Documents

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 34 Item 3:

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 45 Item 4:

Controls and Procedures

Controls and Procedures 45 Part II OTHER INFORMATION 46 Item 1:

Legal Proceedings

Legal Proceedings 46 Item 1A:

Risk Factors

Risk Factors 46 Item 2: Unregistered Sales of Equity Securities and Use of Proceeds 47 Item 5: Other Information 47 Item 6: Exhibits 48

Signatures

Signatures 49 2 Table of Contents

FINANCIAL INFORMATION

PART I FINANCIAL INFORMATION

UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS BRUKER CORPORATION UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (in millions, except share and per share data) September 30, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 148.1 $ 488.3 Accounts receivable, net 538.4 492.0 Inventories 1,220.4 968.3 Other current assets 284.5 215.6 Total current assets 2,191.4 2,164.2 Property, plant and equipment, net 693.9 599.7 Goodwill 1,474.6 582.6 Intangible assets, net 1,026.5 330.5 Operating lease assets 147.5 91.7 Deferred tax assets 340.9 297.2 Other long-term assets 238.1 184.0 Total assets $ 6,112.9 $ 4,249.9 LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND SHAREHOLDERS' EQUITY Current liabilities: Current portion of long-term debt and finance lease obligations $ 32.8 $ 121.2 Accounts payable 227.5 202.7 Deferred revenue and customer advances 466.7 400.0 Other current liabilities 595.1 478.2 Total current liabilities 1,322.1 1,202.1 Long-term debt 2,264.5 1,160.3 Long-term deferred revenue and customer advances 94.2 91.5 Deferred tax liabilities 178.4 67.7 Operating lease liabilities 120.5 74.8 Accrued pension 83.8 76.6 Other long-term liabilities 206.3 163.6 Total liabilities $ 4,269.8 $ 2,836.6 Commitments and contingencies (Note 17) Redeemable noncontrolling interests 18.0 18.7 Shareholders' equity: Preferred stock, $ 0.01 par value 5,000,000 shares authorized, no ne issued or outstanding — — Common stock, $ 0.01 par value 260,000,000 shares authorized, 182,373,563 and 175,943,705 shares issued and 151,594,684 and 145,164,826 shares outstanding at September 30, 2024 and December 31, 2023, respectively 1.8 1.7 Treasury stock, at cost, 30,778,879 shares at September 30, 2024, and December 31, 2023, respectively ( 1,237.2 )

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.